New Mechanism Revealed for Tumor-associated Macrophages to Regulate the Fate of CD8^(+)T Cells

摘要

Immune checkpoint blockade therapy is an efficient way to reinvigorate CD8+T cells,which has demonstrated clinical benefits in multiple types of cancer.However,many patients do not respond to immunotherapies effectively due to the irreversibly dysfunctional state of tumor-infiltrating T cells.